1Heath DA. Primary hyperparathyroidisis clinical presentation and in fluency: clinical management. Eudocrinol Metabclin North Am, 1989, 18:631 - 646.
2Kanaan I, Ahmed M, Rifai A, et al. Sphenoid sinus brown tumor of secondary hyperparathyroidism: case report . Neurosurgery, 1998, 42: 1374- 1377.
3Yilmazlar S, Arslan E, Aksoy K, et al. Sellar - parasellar brown tumor: case report and review of literature . Skull Base, 2004, 3: 163- 168.
4May LG, Gay CV. Multiple G - protein involvement in parathyroid hormone regulation of acid production by osteoclasts . J Cell Biochem, 1997, 64: 161-170.
5Ma YL, Cain RL, Halladay DL, et al. Catabolic effects of continuous human PTH(1 - 38) in vivo is associated with sustained stimulation of RANKAL and inhibition of osteoprotegerin and gene - associated bone formation . Endocrinology, 2001, 142: 4047- 4054.
6Quinn CO, Rajakumar RA, Agapova OA. Parathyroid hormone induces rat interstitial collagenase mRNA through Ets - 1 facilitated by cyclic AMP response element - binding protein and Ca (2 + ) / calmodulin - dependent protein kinase Ⅱ in osteoblastic cells . J mol Endocrinol, 2000, 25:73 - 84.
7Jonsson KB, Zahradnik R, Lasson T, et al. Fibroblast growth factor 23 in oncogenic osteomalacia and X linked hypophos- phatemia. N Engl Med, 2003, 348: 1656- 1663.
8Prince RL, Glendenning P. Disorders of bone and mineral other than osteoporosis . MJA, 2004, 180: 354- 359.
9Jan de Beur SM, Finnegan RB, Vassiliadis J, et al. Tumors associated with oncogenic osteomalacia express genes important in bone and mineral metabolism. J Bone Miner Res, 2002, 17:1102 - 1110.
10Scott SN, Sato y, graham SM, et al. Brown tumor of the palate in a patient with primary hyperparathyroidism . Ann Otol Rhinol Laryngol, 1999, 108: 91- 94.
